| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 138, 413-420, Copyright © 1991 by American Society for Investigative Pathology
REGULAR ARTICLES |
Y Kim, MM Kleppel, R Butkowski, SM Mauer, J Wieslander and AF Michael
Department of Pediatrics, University of Minnesota, Minneapolis 55455.
Diabetic nephropathy is characterized by progressive expansion of mesangial matrix and thickening of the glomerular basement membrane (GBM). Kidney tissues from 13 patients with insulin-dependent diabetes mellitus were studied by immunohistochemical techniques for the distribution of three recently described collagen peptides (M28+, M28 [Good-pasture antigen], and Alport antigen) and various components of classical type IV collagen [alpha 1(IV) noncollagenous (NC) globular domain, alpha 2(IV) NC, 7S, triple helix]. Recently M28 and M28+ were designated as NC monomers of alpha 3(IV) and alpha 4(IV) based on limited amino acid sequencing. During the course of the disease, the distribution of the M28 chains and the Alport peptide segregated completely from that of classical type IV collagen. In diabetic kidneys, antibodies to the M28 and Alport peptides reacted intensely with the thickened GBM but not with the mesangium. In contrast, the reactivity of antibodies to various components of classical type IV collagen was prominent within the expanded mesangial matrix with significant decrease in reactivity in the peripheral capillary wall. In hyalinized glomeruli, components of classical type IV collagen virtually disappeared, whereas the M28 and Alport peptides persisted in the collapsed GBM. These studies support the view that expansion of the mesangial matrix and thickening of the GBM involve separate and distinct collagen components. The differential expression of the M28 and Alport peptides compared with that of classical type IV collagen may be a consequence of differing sites of synthesis (classical type IV collagen from endothelial/mesangial cells and M28 and Alport chains from visceral epithelial cells), independent control mechanisms, and/or differences in degradation.
This article has been cited by other articles:
 |
|
 |
|
  J. Asbun and F. J. Villarreal The Pathogenesis of Myocardial Fibrosis in the Setting of Diabetic Cardiomyopathy J. Am. Coll. Cardiol., February 21, 2006; 47(4): 693 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Ewens, R. A. George, K. Sharma, F. N. Ziyadeh, and R. S. Spielman Assessment of 115 Candidate Genes for Diabetic Nephropathy by Transmission/Disequilibrium Test Diabetes, November 1, 2005; 54(11): 3305 - 3318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Mason and N. A. Wahab Extracellular Matrix Metabolism in Diabetic Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1358 - 1373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mauer, B. Zinman, R. Gardiner, K. N Drummond, S. Suissa, S. M Donnelly, T. D Strand, M. S Kramer, R. Klein, and A. R Sinaiko ACE-I and ARBs in early diabetic nephropathy Journal of Renin-Angiotensin-Aldosterone System, December 1, 2002; 3(4): 262 - 269. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Guo, P. W. Sanders, A. Woods, and C. Wu The Distribution and Regulation of Integrin-Linked Kinase in Normal and Diabetic Kidneys Am. J. Pathol., November 1, 2001; 159(5): 1735 - 1742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Setty, Y. Kim, G. B. Fields, D. O. Clegg, E. A. Wayner, and E. C. Tsilibary Interactions of Type IV Collagen and Its Domains with Human Mesangial Cells J. Biol. Chem., May 15, 1998; 273(20): 12244 - 12249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Annunen, H. Autio-Harmainen, and K. I. Kivirikko The Novel Type II Prolyl 4-Hydroxylase Is the Main Enzyme Form in Chondrocytes and Capillary Endothelial Cells, whereas the Type I Enzyme Predominates in Most Cells J. Biol. Chem., March 13, 1998; 273(11): 5989 - 5992. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
